
Acacia Pharma
Acacia Pharma focuses on the development of nausea and vomiting drugs for the treatment of surgical and cancer patients. Read more
Acacia Pharma focuses on the development of nausea and vomiting drugs for the treatment of surgical and cancer patients. Read more
Acacia Pharma focuses on the development of nausea and vomiting drugs for the treatment of surgical and cancer patients. Read more
CEO
Michael Bolinder
Zuplenz is Acacia Pharma's top competitor. Zuplenz was founded in 2015 in Portland, Oregon. Zuplenz competes in the Pharmaceuticals field. Zuplenz generates $1.5M more revenue than Acacia Pharma.
Coming soon for Acacia Pharma!
Annual Revenue
No recent acquisitions found related to Acacia Pharma
Since Acacia Pharma was founded in 2007, it has participated in 3 rounds of funding. In total Acacia Pharma has raised $63.5M. Acacia Pharma's last funding round was on Jul 2018 for a total of $30.0M
Since Acacia Pharma was founded in 2007, it has participated in 3 rounds of funding. In total Acacia Pharma has raised $63.5M. Acacia Pharma's last funding round was on Jul 2018 for a total of $30.0M
No recent investments found related to Acacia Pharma